Source
UCSF Clinical Trials
1 research study open to eligible people
hATTR is a genetic condition where faulty transthyretin protein builds up as amyloid. UCSF is carrying out an observational study that follows people over months and years. UCSF is collecting clinical notes, test results, and blood samples for analysis.
News Url